In this issue:
A novel immunocompetent animal model for HBV infection
Elbasvir/grazoprevir in HCV & inherited blood disorders
Exploring the mechanism of liver disease progression during HCV
Ginsenoside Rg3 shows strong anti-HCV activity
TDF monotherapy for multiple drug-resistant chronic HBV?
Chronic HCV infection increases risk of ESRD
Underlying mechanisms of protective immunity against HCV
Visualizing HEV infection in human liver tissue
Oral antibiotics ameliorate liver inflammation
ApoE-dependent stimulation of HCV infection
Please login below to download this issue (PDF)